Gritstone Bio Inc (GRTS)
0.9627
+0.09
(+10.66%)
USD |
NASDAQ |
May 03, 16:00
0.9633
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio Total Long Term Debt (Quarterly): 40.14M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 40.14M |
September 30, 2023 | 29.87M |
June 30, 2023 | 29.72M |
March 31, 2023 | 29.58M |
December 31, 2022 | 19.35M |
September 30, 2022 | 19.28M |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
Date | Value |
---|---|
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
40.14M
Maximum
Dec 2023
8.839M
Average
--
Median
Jun 2019
Total Long Term Debt (Quarterly) Benchmarks
Precision BioSciences Inc | 22.41M |
Humacyte Inc | -- |
Verastem Inc | -- |
BioVie Inc | -- |
Adial Pharmaceuticals Inc | -- |